Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.29%||79.74||0.9%||$563.79m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.06%||126.75||2.0%||$276.96m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.50%||343.30||2.7%||$275.56m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.97%||175.66||1.9%||$265.02m|
|A||Agilent Technologies, Inc.||-0.43%||69.88||1.5%||$176.42m|
|EXAS||Exact Sciences Corporation||0.92%||52.57||25.7%||$143.36m|
|SRPT||Sarepta Therapeutics, Inc.||-0.37%||80.92||16.7%||$123.27m|
|BLUE||Bluebird Bio, Inc.||-6.92%||199.80||15.8%||$122.80m|
|BMRN||BioMarin Pharmaceutical Inc.||0.63%||84.10||4.4%||$104.37m|
Immuron Ltd. engages in the research and development of oral immunotherapy treatments using dairy-derived antibody products for humans. It operates through the following segments: Research and Development; HyperImmune Products; and Corporate. The Research and Development segment involves the research and development projects performed in Australia and Israel. The HyperImmune Products segment comprises of Travelan activities which occur in Australia, New Zealand, Canada, and the United States. The Corporate segment covers corporate activities. The company was founded on January 13, 1994 and is headquartered in Southbank, Australia.